Flexner CW, Piscitelli SC. Concentration-targeted therapy and the future of HIV management. AIDS2002;16 (Suppl 1): S1-S3.
2.
Fletcher CV, Cheng H, Fiscus S, et al.The inhibitory quotient (IQ) for saquinavir (SQV) predicts virologic response to salvage therapy. 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 24-28, 2002. (Abstract 129).
3.
Phillips E, Tseng A, Walker S, et al.The use of virtual inhibitory quotient (vIQ) in antiretroviral (ART)-experienced patients taking amprenavir/lopinavir combinations. 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, February 24-28, 2002. (Abstract 130).
4.
Burger D.Therapeutic drug monitoring: A must for clinical practice?1st IAS Conference on HIV Pathogenesis and Treatment. Buenos Aries, Argentina, July 8-11, 2001. (Abstract 54).